News | October 14, 2020

UBC Participates In recent Smallpox Safety Surveillance Study

UBC recently participated in a smallpox safety surveillance study. This prospective study included the enrollment of 20,136 subjects who were active-duty military personnel undergoing pre-deployment medical readiness. The trial was initiated to address safety concerns relating to myopericarditis.

Vaccine is the official journal of The Edward Jenner Society and The Japanese Society for Vaccinology. The literature article was published here on September 13, 2020 with contributions from the Naval Health Research Center, Sanofi Pasteur Inc, Emergent BioSolutions, the Department of Health Policy, Vanderbilt University School of Medicine and UBC.

From conducting clinical trials to meeting post-approval regulatory requirements, we can help guide your infectious disease product or vaccine on its critical path to rapid approval and beyond. UBC’s leadership team have authored and supported countless submissions to regulatory authorities and remain current on the latest global regulatory trends and changes. To learn more about our experience and to discuss how we can support your business continuity during this critical time head here.

D. J. Faix, D. M. Gordon, L. N. Perry et al., Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel, Vaccine,

Source: United BioSource LLC (UBC)